A biological effect is not automatically a memory benefit
This DHA trial did not demonstrate improved cognitive performance over two years, even though supplementation increased a marker of DHA delivery to the central nervous system. That distinction matters when a product is described as good for the brain. Something can reach its intended biological destination without producing a proven benefit that a person can notice. October 22 coverage renewed attention to this trial; its eBioMedicine paper was first published online in June 2026.
What the trial was designed to test
The randomized, double-blind, placebo-controlled trial enrolled 365 adults aged 55–80 without dementia, with low dietary DHA intake and at least one dementia risk factor. It compared high-dose DHA with placebo. The primary question concerned central nervous system target engagement, assessed through the cerebrospinal-fluid DHA-to-arachidonic-acid ratio. DHA increased that marker. Cognitive performance and brain-volume outcomes did not show a demonstrated benefit over 24 months. Substantial dropout, much of it during the pandemic, limits interpretation; cognition was not the primary outcome the trial was powered to establish.
Two sweeping conclusions to avoid
The trial does not establish that fish oil prevents dementia. It also does not establish that every omega-3 product is useless for every purpose, dose and population. A nutrient's role in normal physiology differs from evidence that adding a supplement changes a clinical outcome. Keep your reason for taking a product specific. Do not stop prescribed treatment or a clinician-directed supplement because a general headline addresses a different purpose. The right decision depends on the indication and your circumstances.
Write down the reason before the reminder
A useful supplement review starts with a simple question: why is this in the routine? A hypothetical list might include a clinician recommendation, a dietary concern or an expectation borrowed from advertising. Those are different reasons and deserve different follow-up. Record who recommended the product and what outcome was intended, using a separate note if your tracking tool does not support that context. A daily reminder helps with organization; it cannot establish whether the original reason was supported.
The front of the bottle is not the whole entry
For recordkeeping, check what the label lists per serving, how many capsules make a serving and which ingredient the amount refers to. Total oil and a named component are not interchangeable quantities. Do not combine entries from different products simply because their packaging looks similar. These are label-reading principles, not a recommendation to use the trial dose. A pharmacist or other qualified professional can help review suitability and interactions for your actual product.
Do not use a streak as evidence that it worked
Taking a supplement consistently and benefiting from it are separate questions. A long completion streak documents entries, not improved memory. Likewise, a better day after a capsule does not isolate its effect from sleep, expectations or other changes. If memory problems are new, persistent or affecting daily life, seek assessment rather than escalate a supplement experiment. Keeping the record clear can support that conversation without turning the app into a cognitive test.
Where Connefi fits
Connefi can organize supplement routines with recorded doses, timing and taken status, alongside meals and workouts. Known nutrition depends on the selected product information; unknown potency is not inferred. PERI's supported suggestions remain subject to review and are not a substitute for medication or supplement advice. Connefi does not measure cerebrospinal-fluid DHA, assess memory or establish that a product prevents dementia. Use the routine to remember what was planned while keeping the evidence question separate.
Ask for the outcome that matters
Before accepting a supplement claim, look for the link between the measured biological change and the promised personal benefit. This trial is useful precisely because those answers differed. Keep a specific reason for any product, review it with an appropriate professional when needed and resist treating adherence as proof. A well-organized routine should make uncertainty easier to discuss, not hide it behind a completed checkbox.
Research & sources
Research provides context; it does not validate Connefi’s exact scores or establish individual outcomes.